【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Chemotherapy Induced Nausea and Vomiting 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 21
Clinical Trials in E7 Nations by Trial Status 22
Clinical Trials by Phase 23
In Progress Trials by Phase 24
Clinical Trials by Trial Status 25
Unaccomplished Trials of Chemotherapy Induced Nausea and Vomiting 26
Subjects Recruited Over a Period of Time 30
Prominent Sponsors 31
Top Companies Participating in Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials 33
Prominent Drug Comparison 35
Clinical Trial Profiles 36
Clinical Trial Overview of Top Companies 36
Merck & Co., Inc. 36
Clinical Trial Overview of Merck & Co., Inc. 36
GlaxoSmithKline plc 38
Clinical Trial Overview of GlaxoSmithKline plc 38
Helsinn Healthcare S.A. 40
Clinical Trial Overview of Helsinn Healthcare S.A. 40
ProStrakan Group plc 42
Clinical Trial Overview of ProStrakan Group plc 42
Tesaro, Inc. 43
Clinical Trial Overview of Tesaro, Inc. 43
Acacia Pharma Ltd. 44
Clinical Trial Overview of Acacia Pharma Ltd. 44
Mylan Pharmaceuticals Inc. 45
Clinical Trial Overview of Mylan Pharmaceuticals Inc. 45
A.P. Pharma, Inc. 46
Clinical Trial Overview of A.P. Pharma, Inc. 46
Par Pharmaceutical Companies, Inc. 47
Clinical Trial Overview of Par Pharmaceutical Companies, Inc. 47
Ono Pharmaceutical Co., Ltd. 48
Clinical Trial Overview of Ono Pharmaceutical Co., Ltd. 48
Insys Therapeutics, Inc. 49
Clinical Trial Overview of Insys Therapeutics, Inc. 49
RedHill Biopharma Ltd. 50
Clinical Trial Overview of RedHill Biopharma Ltd. 50
Dr. Reddy’s Laboratories Limited 51
Clinical Trial Overview of Dr. Reddy’s Laboratories Limited 51
Solasia Pharma K.K. 52
Clinical Trial Overview of Solasia Pharma K.K. 52
LG Life Sciences, Ltd. 53
Clinical Trial Overview of LG Life Sciences, Ltd. 53
IPCA Laboratories Limited 54
Clinical Trial Overview of IPCA Laboratories Limited 54
Eisai Inc. 55
Clinical Trial Overview of Eisai Inc. 55
Halozyme Therapeutics, Inc. 56
Clinical Trial Overview of Halozyme Therapeutics, Inc. 56
Schering-Plough Corporation (Inactive) 57
Clinical Trial Overview of Schering-Plough Corporation (Inactive) 57
Teva Pharmaceutical Industries Limited 58
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 58
Clinical Trial Overview of Top Institutes / Government 59
The University of Texas M. D. Anderson Cancer Center 59
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 59
University of Rochester 60
Clinical Trial Overview of University of Rochester 60
Memorial Sloan Kettering Cancer Center 61
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 61
Kitasato University School of Medicine 62
Clinical Trial Overview of Kitasato University School of Medicine 62
Duke University 63
Clinical Trial Overview of Duke University 63
OHSU Knight Cancer Institute 64
Clinical Trial Overview of OHSU Knight Cancer Institute 64
Yokohama City University 65
Clinical Trial Overview of Yokohama City University 65
Tokushima University Hospital 66
Clinical Trial Overview of Tokushima University Hospital 66
Washington University School of Medicine 67
Clinical Trial Overview of Washington University School of Medicine 67
National Cancer Institute 68
Clinical Trial Overview of National Cancer Institute 68
University of Oklahoma 69
Clinical Trial Overview of University of Oklahoma 69
Kyoto University 70
Clinical Trial Overview of Kyoto University 70
University of Washington 71
Clinical Trial Overview of University of Washington 71
All India Institute of Medical Sciences 72
Clinical Trial Overview of All India Institute of Medical Sciences 72
The Hospital for Sick Children 73
Clinical Trial Overview of The Hospital for Sick Children 73
Thomas Jefferson University 74
Clinical Trial Overview of Thomas Jefferson University 74
Gynecologic Oncology Group 75
Clinical Trial Overview of Gynecologic Oncology Group 75
Kobe University 76
Clinical Trial Overview of Kobe University 76
The University of Manchester 77
Clinical Trial Overview of The University of Manchester 77
Shizuoka Cancer Center 78
Clinical Trial Overview of Shizuoka Cancer Center 78
Five Key Clinical Profiles 79
Appendix 153
Abbreviations 153
Definitions 153
Research Methodology 154
Secondary Research 154
About GlobalData 155
Contact Us 155
Disclaimer 155
Source 156
【レポート販売概要】
■ タイトル：Chemotherapy Induced Nausea and Vomiting：グローバル臨床試験レビューH2, 2013■ 英文：Chemotherapy Induced Nausea and Vomiting Global Clinical Trials Review, H2, 2013
■ 発行日：2013年9月30日
■ 調査会社：GlobalData
■ 商品コード：GDATA403162123
■ 調査対象地域：グローバル
- 卵巣癌治療薬の世界市場2019-2023About this market Ovarian cancer is the second most common gynecologic cancer, and the incidence of the disease has been increasing. The incidence of ovarian cancer increases with age, mainly due to the cell DNA damage associated with age as a result of biological processes or due to the exposure to risk factors. In terms of the incidence rate, ovarian cancer is the eighth-most commonly occurring …
- dL-イソクエン酸ラクトンの世界市場DL-Isocitric Acid Lactone (CAS 4702-32-3) Market Research Report 2013 presents comprehensive data on dl-isocitric acid lactone markets globally and regionally (Europe, Asia, North America etc.) The DL-Isocitric Acid Lactone (CAS 4702-32-3) Market Research Report 2013 includes dl-isocitric acid lactone description, covers its application areas and related patterns. It overviews dl-isocitric acid la …
- Practice Management System（医療用情報管理システム）の世界市場（～2018）The Practice management (PM) system offers advanced scheduling, patient registration, medical billing, stores demographic data, claims management, and reporting. The developing markets of Middle East, Australia, New Zealand, China, India, Singapore and Malaysia were identified as high growth markets due to favorable government incentives and developing IT infrastructure In addition, the cloud–base …
- 養殖用ケージの世界市場2019-2023About this market Growing popularity of offshore aquaculture to drive growth in the market. Offshore aquaculture is a rapidly expanding aquaculture activity and plays a key role in the growth of the market. It enables increased seafood production to meet the growing demand. Fish such as finfish, shellfish. and prawns are commonly cultured through offshore aquaculture. Offshore aquaculture also off …
- コードレス掃除機の世界市場：種類別、用途別（商業、住宅）、地域別予測Global Cordless Vacuum Cleaner Market to reach USD 29 billion by 2025. Global Cordless Vacuum Cleaner Market valued approximately USD 19.85 billion in 2016 is anticipated to grow with a healthy growth rate of more than 4.30% over the forecast period 2017-2025. A vacuum cleaner is a device that uses an air pump to create a partial vacuum to suck up dust and dirt, usually from floors, and from other …
- 不安障害（Anxiety Disorder）治療薬の世界市場2015-2019About Anxiety Disorders Anxiety is associated with uneasiness, fearfulness, and tension. Mild anxiety, for example, associated with exams or interview, is normal and triggers 'fight or flight' response. Anxiety without an identifiable cause, anxiety which persists even after the stressful condition is over, and anxiety which is out of proportion of the stressful condition indicates abnormal anxiet …
- シュガーフリー食品・飲料の世界市場2017-2021About Sugar-Free Foods The global sugar-free food and beverages market has been registering positive growth over the last few years and is shaping up to become one of the top competitive markets at a global level. With the rise in globalization, ample growth opportunities are being created in the market. Technavio’s analysts forecast the global sugar-free foods market to grow at a CAGR of 10.16% d …
- Talisman Energy Inc.：石油・ガスバリューチェーン分析レポート2013Talisman Energy Inc. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Talisman Energy Inc." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Talisman Energy Inc.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report exam …
- PDMS（ポリジメチルシロキサン）の世界市場予測（～2024年）“Growing PDMS consumption in personal care, medical, automotive, construction industries is expected to drive the PDMS market.” The polydimethylsiloxane (PDMS) market size is estimated to be USD 4.0 billion in 2019 and is projected to reach USD 5.2 billion by 2024, at a CAGR of 6.0%. The increasing demand for PDMS from industries such as personal care, medical, automotive, construction and others …
- アメリカのスポーツ栄養市場2016-2020Sports nutrition products are specially made products that help a consumer to enhance performance, health, and energy and build muscles. Furthermore, these products are also a good source of various fortified nutrients, including proteins, vitamins, minerals, carbohydrates, and fats. In the US, the concept of sports nutrition has gained popularity over the past few years, mainly due to the increas …
- Lea County Electric Cooperative, Inc.：発電所及びSWOT分析2013Lea County Electric Cooperative, Inc. - Power Plants and SWOT Analysis, 2013 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets …
- 幹細胞治療の世界市場予測（～2021年）：同種幹細胞、自己幹細胞The global stem cell therapy market is estimated to grow at a CAGR of 11.0% during 2016 to 2021 to reach USD 145.8 million by 2021. Growth in the global stem cell therapy market is driven by factors such as the growing awareness of the therapeutic potency of stem cells in effective disease management, development of advanced genome-based cell analysis techniques, increasing public-private investme …
- 世界のモバイル通信への企業支出動向（2012-2016）TechNavio's analysts forecast the Global Enterprise Spending on Mobile Communication to grow at a CAGR of 4.72 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing need for enterprise mobility. The Global Enterprise Spending on Mobile Communication space has also been witnessing the growing availability of corporate communication packages. …
- オンライン言語学習の世界市場About the Online Language Learning Market Online language learning consists of digital content and solutions that facilitate the learning of languages through ICT tools and platforms, such as mobile apps, e-Books, games, videos, audio clips, digital software, learning lab equipment, and online tutoring. These tools and avenues are interactive, allow real-time feedback, and enhance learning process …
- 化学療法誘発性骨髄抑制(Chemotherapy Induced Myelosuppression)：治療薬開発パイプライン動向（2015年上半期版）Chemotherapy Induced Myelosuppression - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Chemotherapy Induced Myelosuppression - Pipeline Review, H1 2015’, provides an overview of the Chemotherapy Induced Myelosuppression’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Chemotherapy Induced Myelosuppression, complete with comparati …
